877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

www.sigmaaldrich.com, Drugs acting on the genito-urinary system, CYP17A1 inhibitors, Anti-diabetic drugs, Antiglucocorticoids, PPAR agonists

Categories

Antiandrogens (3)
Drugs acting on the gastrointestinal system and metabolism (3)
Hormonal agents (3)
Pharmaceuticals (3)
Sex hormones (3)
Systemic hormonal preparations (3)
Thiazolidinediones (3)
Cyclic compounds (2)
Pyridines (2)
Six-membered rings (2)
Antineoplastic and immunomodulating drugs (1)
Antineoplastic drugs (1)
Aromatase inhibitors (1)
Hormonal antineoplastic drugs (1)

Suppliers

AK Scientific (2)
Matrix Scientific (1)
Oakwood Chemical (1)
Toronto Research Chemicals (1)
TCI Chemicals (1)

Pioglitazone (111025-46-8)  
Actos  ·  pioglitazone hydrochloride  ·  U72,107A
Pioglitazone (brand name Actos) is a prescription drug of the thiazolidinedione (TZD) class with hypoglycemic (antihyperglycemic, antidiabetic) action to treat diabetes. While pioglitazone does decrease blood sugar levels, studies on the main cardiovascular outcomes have not yielded statistically significant results. Its cardiovascular safety profile compares favorably with that of rosiglitazone, which was withdrawn from some markets after concerns about an increased risk of cardiac events.
rosiglitazone (122320-73-4)  
Rosiglitazone (trade name Avandia) is an antidiabetic drug in the thiazolidinedione class. It works as an insulin sensitizer, by binding to the PPAR in fat cells and making the cells more responsive to insulin. It is marketed by the pharmaceutical company GlaxoSmithKline (GSK) as a stand-alone drug or for use in combination with metformin or with glimepiride.
troglitazone (97322-87-7)  
Troglitazone (Rezulin, Resulin, Romozin, Noscal) is an antidiabetic and anti-inflammatory drug, and a member of the drug class of the thiazolidinediones. It was prescribed for patients with diabetes mellitus type 2. It was developed by Daiichi Sankyo (Japan).
Related searches
www.sigmaaldrich.com
Drugs acting on the genito-urinary system
CYP17A1 inhibitors
Anti-diabetic drugs
Antiglucocorticoids
PPAR agonists